Cargando…
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
BACKGROUND: Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients. METHODS: Data on all neoadjuvant treated breast cancer patients in Southern Swe...
Autores principales: | Skarping, Ida, Förnvik, Daniel, Sartor, Hanna, Heide-Jørgensen, Uffe, Zackrisson, Sophia, Borgquist, Signe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937786/ https://www.ncbi.nlm.nih.gov/pubmed/31888552 http://dx.doi.org/10.1186/s12885-019-6485-4 |
Ejemplares similares
-
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
por: Skarping, Ida, et al.
Publicado: (2020) -
Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden
por: Skarping, Ida, et al.
Publicado: (2020) -
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021) -
Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy
por: Zdanowski, Anna, et al.
Publicado: (2023) -
Effects of statin use on volumetric mammographic density: results from the KARMA study
por: Skarping, Ida, et al.
Publicado: (2015)